drugset / Trial / NCT06310642

Efficacy of Prophylactic Treatment of Oral Prochlorperazine for Acute Mountain Sickness

NCT06310642

Phase 4 Completed 30 enrolled CHRISTUS Health
RandomizedParallel-groupSingle-blindTreatment

Summary

A field-based trial was conducted to determine if oral prochlorperazine demonstrates efficacy in the prophylactic treatment of AMS, and/or decreases the incidence of the symptoms of acute mountain sickness including headache, GI symptoms, fatigue and dizziness based on data collected in the Lake Louise AMS score.

Timeline

Start
2021-05-20
Primary completion
2023-03-13
Completion
2023-03-13

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Prochlorperazine Small molecule 10 mg Oral
Background Diphenhydramine Unknown